home / stock / glaxf / glaxf news


GLAXF News and Press, GlaxoSmithKline Plc From 01/13/26

Stock Information

Company Name: GlaxoSmithKline Plc
Stock Symbol: GLAXF
Market: OTC
Website: gsk.com

Menu

GLAXF GLAXF Quote GLAXF Short GLAXF News GLAXF Articles GLAXF Message Board
Get GLAXF Alerts

News, Short Squeeze, Breakout and More Instantly...

GLAXF - GSK plc (GSK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-13 14:46:01 ET GSK plc (GSK) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 10:30 AM EST... Read the full article on Seeking Alpha For further details see: GSK plc (GSK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

GLAXF - GSK Still Has Room To Run Despite Vaccine Cyclicality

2026-01-12 09:00:00 ET ... Read the full article on Seeking Alpha For further details see: GSK Still Has Room To Run Despite Vaccine Cyclicality

GLAXF - GSK: 2026 Looks Good

2025-12-18 16:25:34 ET It has been a very good year for the British pharmaceutical stock GSK plc ( GSK ), which is up by ~46% YTD. This far exceeds the performance of the healthcare sector, as evident from the 13.5% returns on the State Street Health Care Select Sector SPDR ETF ( ...

GLAXF - Chasing Bubbles And Riding Value In Another Year Leading The S&P 500

2025-12-14 12:15:58 ET Introduction As “bandwagon” investors join any party, they create their own truth — for a while . ~ Warren Buffett Read the full article on Seeking Alpha For further details see: Chasing Bubbles And Riding Value In ...

GLAXF - GSK: Depemokimab And Jemperli Lead Next Wave (Rating Upgrade)

2025-12-12 16:42:47 ET Over the past two months, that is how much time has passed since my article "GSK's Hidden Growth Engines Beyond HIV and Oncology," GSK's shares ( GSK ) ( GLAXF ) have risen by 12.5%.... Read the full article on Seeking Alpha For further details...

GLAXF - Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3

2025-11-27 07:20:44 ET Introduction As the year comes to an end, we must be thankful for the therapies that are in late clinical stages. Most importantly, patients are set to benefit immensely. But nearly every trial candidate has implications beyond just patients. The approval of a...

GLAXF - Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth

2025-11-21 16:03:13 ET In my article from October, "My Top 5 Biotech Stocks Big Pharma Could Buy Next," I mentioned how Phathom Pharmaceutical's ( PHAT ) Voquezna and Voquezna Triple Pak is actively capturing share in the U.S. GERD and H. pylori infection treatment markets. ... ...

GLAXF - GSK plc (GSK) Presents at Jefferies London Healthcare Conference 2025 Transcript

2025-11-19 11:23:29 ET GSK plc (GSK) Jefferies London Healthcare Conference 2025 November 19, 2025 4:30 AM EST... Read the full article on Seeking Alpha For further details see: GSK plc (GSK) Presents at Jefferies London Healthcare Conference 2025 Transcript

GLAXF - GSK plc (GSK) Q3 2025 Earnings Call Transcript

2025-10-29 12:46:35 ET GSK plc (GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Emma Walmsley - CEO & Director Luke Miels - Chief Commercial Officer Deborah Waterhouse - CEO of ViiV Healthcare & President of Global Health ...

GLAXF - Moderna Vs BioNTech: Who's Winning The Post-COVID Race

2025-10-18 09:30:00 ET And so, I've reached the publication of the sixth article, following "Pfizer vs. Johnson & Johnson: Who's the Better Bargain for Investors" and "Eli Lilly vs. Novo Nordisk: Which Is the Better Bargain for Investors," in a series of comparison analyses of t...

Previous 10 Next 10